|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/16 |
| (11) | Patento numeris | 1937219 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 06803680.5 |
| Europos patento paraiškos padavimo data | 2006-09-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2008-07-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-11-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2006/036034 |
| Data | 2006-09-14 |
| (87) | Numeris | WO 2007/033372 |
| Data | 2007-03-22 |
| (30) | Numeris | Data | Šalis |
| 717524 P | 2005-09-14 | US | |
| 744882 P | 2006-04-14 | US |
| (72) |
OBERG, Keith A., US
|
| (73) |
MannKind Corporation,
25134 Rye Canyon Loop, Valencia CA 91355,
US
|
| (54) | METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF CRYSTALLINE MICROPARTICLE SURFACES FOR ACTIVE AGENTS |
| METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF CRYSTALLINE MICROPARTICLE SURFACES FOR ACTIVE AGENTS |